KLK3 and Familial prostate cancer: To address this issue, we evaluated the accuracy of EPI in the prior negative biopsy population using the AUC and compared results with PSA alone and a well-established risk calculator, the European Randomized Study of Screening for Prostate Cancer (ERSPC) [13, 14].